Fidelity Investments’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $105K | Sell |
39,010
-3,128
| -7% | -$8.07K | ﹤0.01% | 3953 |
|
|
2026
Q1 | $93.5K | Sell |
42,138
-1,836
| -4% | -$3.28K | ﹤0.01% | 3817 |
|
|
2025
Q4 | $71.7K | Sell |
43,974
-3,013
| -6% | -$4.64K | ﹤0.01% | 3922 |
|
|
2025
Q3 | $61.1K | Sell |
46,987
-1
| -0% | -$1 | ﹤0.01% | 3883 |
|
|
2025
Q2 | $15.5K | Buy |
46,988
+16,091
| +52% | +$4.85K | ﹤0.01% | 4381 |
|
|
2025
Q1 | $9.64K | Sell |
30,897
-4,019
| -12% | -$2.47K | ﹤0.01% | 4512 |
|
|
2024
Q4 | $32.6K | Sell |
34,916
-15,309
| -30% | -$17.1K | ﹤0.01% | 4029 |
|
|
2024
Q3 | $59.3K | Buy |
50,225
+47,723
| +1,907% | +$49.9K | ﹤0.01% | 3711 |
|
|
2024
Q2 | $1.93K | Sell |
2,502
-83,705
| -97% | -$233K | ﹤0.01% | 4729 |
|
|
2024
Q1 | $263K | Buy |
86,207
+982
| +1% | +$3.29K | ﹤0.01% | 2938 |
|
|
2023
Q4 | $274K | Sell |
85,225
-6,281
| -7% | -$21.5K | ﹤0.01% | 2859 |
|
|
2023
Q3 | $351K | Sell |
91,506
-19
| -0% | -$68 | ﹤0.01% | 2723 |
|
|
2023
Q2 | $300K | Buy |
91,525
+125
| +0.1% | +$424 | ﹤0.01% | 2823 |
|
|
2023
Q1 | $236K | Hold |
91,400
| – | – | ﹤0.01% | 2923 |
|
|
2022
Q4 | $170K | Sell |
91,400
-1,257
| -1% | -$2.14K | ﹤0.01% | 3050 |
|
|
2022
Q3 | $170K | Sell |
92,657
-2,000
| -2% | -$4.18K | ﹤0.01% | 3095 |
|
|
2022
Q2 | $204K | Buy |
94,657
+444
| +0.5% | +$1.07K | ﹤0.01% | 3123 |
|
|
2022
Q1 | $296K | Buy |
94,213
+93,213
| +9,321% | +$293K | ﹤0.01% | 3147 |
|
|
2021
Q4 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 3941 |
|
|
2021
Q3 | $3K | Buy |
+1,000
| New | +$3.65K | ﹤0.01% | 3918 |
|
|
2020
Q4 | – | Sell |
-1,708,646
| Closed | -$9.81M | – | 4168 |
|
|
2020
Q3 | $9.81M | Sell |
1,708,646
-72,569
| -4% | -$486K | ﹤0.01% | 1841 |
|
|
2020
Q2 | $13.1M | Sell |
1,781,215
-303,685
| -15% | -$1.42M | ﹤0.01% | 1713 |
|
|
2020
Q1 | $6.21M | Hold |
2,084,900
| – | – | ﹤0.01% | 1857 |
|
|
2019
Q4 | $8.65M | Buy |
+2,084,900
| New | +$6.58M | ﹤0.01% | 1896 |
|
|
2018
Q4 | – | Sell |
-1,015,805
| Closed | -$5.76M | – | 3961 |
|
|
2018
Q3 | $5.76M | Sell |
1,015,805
-298,019
| -23% | -$2.26M | ﹤0.01% | 2108 |
|
|
2018
Q2 | $10.2M | Sell |
1,313,824
-71,242
| -5% | -$612K | ﹤0.01% | 1936 |
|
|
2018
Q1 | $9.79M | Sell |
1,385,066
-88,807
| -6% | -$718K | ﹤0.01% | 1966 |
|
|
2017
Q4 | $14.5M | Sell |
1,473,873
-171,172
| -10% | -$1.57M | ﹤0.01% | 1832 |
|
|
2017
Q3 | $13.8M | Sell |
1,645,045
-169,802
| -9% | -$1.41M | ﹤0.01% | 1830 |
|
|
2017
Q2 | $18.3M | Buy |
+1,814,847
| New | +$23.7M | ﹤0.01% | 1715 |
|
Other funds holding OVID
JT
EAM
RCM
AAA
ACM
Fidelity Investments's OVID Position: Q2 2026 in Review
Fidelity Investments reduced its Ovid Therapeutics (OVID) stake by 7.4% in Q2 2026, selling an estimated $8.07K and leaving 39,010 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #3953.
Fidelity Investments first reported a position in OVID in Q2 2017 and has held it in 30 quarters since. The position peaked at $18.3M in Q2 2017. 131 funds tracked by Wall St. Rank hold OVID as of Q2 2026.
- Fidelity Investments held 39,010 shares of Ovid Therapeutics worth $105K as of Q2 2026.
- Fidelity Investments sold 3,128 Ovid Therapeutics shares in Q2 2026, an estimated $8.07K.
- Ovid Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3953 holding.
- Fidelity Investments first reported a position in Ovid Therapeutics in Q2 2017 and has held it in 30 quarters since.
- Fidelity Investments's Ovid Therapeutics position peaked at $18.3M in Q2 2017.
- 131 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.
Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.